-
Study aim
-
Effect of analgesia with intravenous remifentanil versus intravenous pethidine on maternal and neonatal complications and maternal satisfaction with labor during active phase of labor
-
Design
-
Two arm parallel group randomised trial with blinded patients and outcome assessment
-
Settings and conduct
-
The research population was pregnant women referred to normal delivery in the Shahid Ayat Taleghani Hospital. Pregnant women, in the age range of 18 to 45 years old with a gestational age of 37 to 42, cephalalgia, lack of drug addiction, absence of malformation or disease in mother and fetus will be selected.Participants in the study, including a patient, an analyzer who will be analyzed patient information, will be unaware of the study program.
-
Participants/Inclusion and exclusion criteria
-
Pregnant women, in the age range of 18 to 45 years old with a gestational age of 37 to 42, cephalalgia, lack of drug addiction, absence of malformation or disease in mother and fetus will be selected, and if they receive any analgesic drug within three hours Before starting the study, they will be excluded from the study.
-
Intervention groups
-
Two groups 60,peittidine intravenous analgesia and analgesia will be allocated by the intravenous injection of Remifentanil.
In the anesthetic group with pethidine, 25 mg / day of the drug will be diluted with 4 cc distilled water (2-3 minutes). Intervention in the analgesic group with the injection of remi-fentanyl, 10-5 micrograms of remifentanil, will be started by anesthetist for intravenous infusion.
-
Main outcome variables
-
The pain in the lower part of the lumbar will be measured once before the intervention and then at 5, 10, 20, 30 minutes after intervention and then every hour by inserting the maternal finger across the ruler in both groups.